Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Alzheimer's Disease

  Free Subscription


18.03.2024

2 Acta Neuropathol
3 Alzheimers Dement
1 Ann Neurol
3 Biochemistry (Mosc)
2 BMC Geriatr
1 Brain
3 Curr Alzheimer Res
20 J Alzheimers Dis
1 J Neurol Neurosurg Psychiatry
2 Nature
1 Nervenarzt
1 Neurobiol Aging
1 Neurologia (Engl Ed)
9 Neurology
1 PLoS One
1 Science


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Neuropathol

  1. WALTON RL, Koga S, Beasley AI, White LJ, et al
    Role of GBA variants in Lewy body disease neuropathology.
    Acta Neuropathol. 2024;147:54.
    PubMed         Abstract available

  2. XU H, Qiu Q, Hu P, Hoxha K, et al
    MSUT2 regulates tau spreading via adenosinergic signaling mediated ASAP1 pathway in neurons.
    Acta Neuropathol. 2024;147:55.
    PubMed         Abstract available


    Alzheimers Dement

  3. MAESTRE G, Hill C, Griffin P, Hall S, et al
    Promoting diverse perspectives: Addressing health disparities related to Alzheimer's and all dementias.
    Alzheimers Dement. 2024 Mar 9. doi: 10.1002/alz.13752.
    PubMed         Abstract available

  4. GARCIA-AGUDO LF, Shi Z, Smith IF, Kramar EA, et al
    BIN1(K358R) suppresses glial response to plaques in mouse model of Alzheimer's disease.
    Alzheimers Dement. 2024 Mar 9. doi: 10.1002/alz.13767.
    PubMed         Abstract available

  5. HOWARD R, Cort E, Rawlinson C, Wiegand M, et al
    Adapted problem adaptation therapy for depression in mild to moderate Alzheimer's disease dementia: A randomized controlled trial.
    Alzheimers Dement. 2024 Mar 13. doi: 10.1002/alz.13766.
    PubMed         Abstract available


    Ann Neurol

  6. PALPATZIS E, Akinci M, Aguilar-Dominguez P, Garcia-Prat M, et al
    Lifetime Stressful Events Associated with Alzheimer's Pathologies, Neuroinflammation and Brain Structure in a Risk Enriched Cohort.
    Ann Neurol. 2024 Mar 11. doi: 10.1002/ana.26881.
    PubMed         Abstract available


    Biochemistry (Mosc)

  7. GUSEVA EA, Pavlova JA, Dontsova OA, Sergiev PV, et al
    Synthetic Activators of Autophagy.
    Biochemistry (Mosc). 2024;89:27-52.
    PubMed         Abstract available

  8. EREMIN DV, Kondaurova EM, Rodnyy AY, Molobekova CA, et al
    Serotonin Receptors as a Potential Target in the Treatment of Alzheimer's Disease.
    Biochemistry (Mosc). 2023;88:2023-2042.
    PubMed         Abstract available

  9. BURNYASHEVA AO, Stefanova NA, Kolosova NG, Telegina DV, et al
    Changes in the Glutamate/GABA System in the Hippocampus of Rats with Age and during Alzheimer's Disease Signs Development.
    Biochemistry (Mosc). 2023;88:1972-1986.
    PubMed         Abstract available


    BMC Geriatr

  10. GE S, Dong F, Tian C, Yang CH, et al
    Serum soluble alpha-klotho klotho and cognitive functioning in older adults aged 60 and 79: an analysis of cross-sectional data of the National Health and Nutrition Examination Survey 2011 to 2014.
    BMC Geriatr. 2024;24:245.
    PubMed         Abstract available

  11. LEE KW, Hong YJ, Yang EJ, Lee SB, et al
    Feasibility and usefulness of cognitive monitoring using a new home-based cognitive test in mild cognitive impairment: a prospective single arm study.
    BMC Geriatr. 2024;24:241.
    PubMed         Abstract available


    Brain

  12. RODRIGUEZ-RODRIGUEZ P, Arroyo-Garcia LE, Tsagkogianni C, Li L, et al
    A cell autonomous regulator of neuronal excitability modulates tau in Alzheimer's disease vulnerable neurons.
    Brain. 2024 Mar 11:awae051. doi: 10.1093.
    PubMed         Abstract available


    Curr Alzheimer Res

  13. DE A, Mishra TK, Saraf S, Tripathy B, et al
    A Review onthe Use of Modern Computational Methods in Alzheimer's Disease-Detection and Prediction.
    Curr Alzheimer Res. 2024 Mar 8. doi: 10.2174/0115672050301514240307071217.
    PubMed         Abstract available

  14. WEAVER D
    Drug Design for Alzheimer's Disease: Biologics vs. Small Molecules.
    Curr Alzheimer Res. 2024 Mar 8. doi: 10.2174/0115672050301583240307114452.
    PubMed         Abstract available

  15. YAO J, Kan B, Dong Z, Tang Z, et al
    Research Progress of Mitophagy in Alzheimer's Disease.
    Curr Alzheimer Res. 2024 Mar 12. doi: 10.2174/0115672050300063240305074310.
    PubMed         Abstract available


    J Alzheimers Dis

  16. SHEN Z, Yang X, Lan Y, Chen G, et al
    The Neuro-Inflammatory Microenvironment: An Important Regulator of Stem Cell Survival in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 13. doi: 10.3233/JAD-231159.
    PubMed         Abstract available

  17. CAO J, Tang Y, Chen S, Yu S, et al
    The Hippocampal Subfield Volume Reduction and Plasma Biomarker Changes in Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-231114.
    PubMed         Abstract available

  18. TRIEU C, van Harten AC, Leeuwis AE, Exalto LG, et al
    Alzheimer's Disease and Cognitive Decline in Patients with Cardiovascular Diseases Along the Heart-Brain Axis.
    J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-231096.
    PubMed         Abstract available

  19. ZHANG X, Gomez L, Below JE, Naj AC, et al
    An X Chromosome Transcriptome Wide Association Study Implicates ARMCX6 in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 14. doi: 10.3233/JAD-231075.
    PubMed         Abstract available

  20. RAMADAN FA, Arani G, Jafri A, Thompson T, et al
    Mendelian Randomization of Blood Metabolites Suggests Circulating Glutamine Protects Against Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 13. doi: 10.3233/JAD-231063.
    PubMed         Abstract available

  21. ZHAI M, Zhang Y, Yan D, Wang Y, et al
    Genetic Insights into the Association and Causality Between Blood Metabolites and Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-230985.
    PubMed         Abstract available

  22. CESANA BM, Bergh S, Ciccone A, Cognat E, et al
    Predictors of Nursing Home Placement in a Cohort of European People with Alzheimer's Disease and Other Dementia Cases Enrolled in SCU-B or Non SCU-B Centers: The RECage Study.
    J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-230878.
    PubMed         Abstract available

  23. MANDAL PK
    Pro-Oxidants and Antioxidants Imbalance in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 4. doi: 10.3233/JAD-240217.
    PubMed        

  24. TERAO I, Kodama W
    Comparative Efficacy, Tolerability, and Acceptability of Donanemab, Lecanemab, Aducanumab, Melatonin, and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer's Disease: A Systematic Review and Networ
    J Alzheimers Dis. 2024 Mar 6. doi: 10.3233/JAD-230911.
    PubMed         Abstract available

  25. SIAFARIKAS N
    Neuropsychiatric and Cognitive Symptoms: Two Sides of the Same Coin?
    J Alzheimers Dis. 2024;98:75-78.
    PubMed         Abstract available

  26. MATSUZONO K, Mashiko T, Koide R, Yoshizumi H, et al
    Comparison of Prognosis and Cognitive Function of Holistic Neurological Disease: Tochigi Neurological Disease Cohort Study.
    J Alzheimers Dis. 2024;98:275-285.
    PubMed         Abstract available

  27. NALLAPU BT, Petersen KK, Lipton RB, Davatzikos C, et al
    Plasma Biomarkers as Predictors of Progression to Dementia in Individuals with Mild Cognitive Impairment.
    J Alzheimers Dis. 2024;98:231-246.
    PubMed         Abstract available

  28. PRABHAKARAN D, Grant C, Pedraza O, Caselli R, et al
    Machine Learning Predicts Conversion from Normal Aging to Mild Cognitive Impairment Using Medical History, APOE Genotype, and Neuropsychological Assessment.
    J Alzheimers Dis. 2024;98:83-94.
    PubMed         Abstract available

  29. ROSS JP, Post SG, Scheinfeld L
    Lucidity in the Deeply Forgetful: A Scoping Review.
    J Alzheimers Dis. 2024;98:3-11.
    PubMed         Abstract available

  30. PUTIGNANO S, Forgione L, Fusco M, Giacummo A, et al
    Early Detection Screening of Cognitive Decline in Patients Over 60 Years: ELDERCARE Study.
    J Alzheimers Dis. 2024;98:145-150.
    PubMed         Abstract available

  31. ALJASSABI A, Zieneldien T, Kim J, Regmi D, et al
    Alzheimer's Disease Immunotherapy: Current Strategies and Future Prospects.
    J Alzheimers Dis. 2024 Mar 14. doi: 10.3233/JAD-231163.
    PubMed         Abstract available

  32. BROOKS WH
    Polyamine Dysregulation and Nucleolar Disruption in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-231184.
    PubMed         Abstract available

  33. SOARES MARTINS T, Ferreira M, Magalhaes S, Leandro K, et al
    FTIR Spectroscopy and Blood-Derived Extracellular Vesicles Duo in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 14. doi: 10.3233/JAD-231239.
    PubMed         Abstract available

  34. CABRERA-LEON Y, Baez PG, Fernandez-Lopez P, Suarez-Araujo CP, et al
    Neural Computation-Based Methods for the Early Diagnosis and Prognosis of Alzheimer's Disease Not Using Neuroimaging Biomarkers: A Systematic Review.
    J Alzheimers Dis. 2024 Mar 10. doi: 10.3233/JAD-231271.
    PubMed         Abstract available

  35. ZHONG P, Cao Q, Yan Z
    Distinct and Convergent Alterations of Entorhinal Cortical Circuits in Two Mouse Models for Alzheimer's Disease and Related Disorders.
    J Alzheimers Dis. 2024 Mar 14. doi: 10.3233/JAD-231413.
    PubMed         Abstract available


    J Neurol Neurosurg Psychiatry

  36. ANDERSON EL, Davies NM, Korologou-Linden R, Kivimaki M, et al
    Dementia prevention: the Mendelian randomisation perspective.
    J Neurol Neurosurg Psychiatry. 2024;95:384-390.
    PubMed         Abstract available


    Nature

  37. LANDHUIS E
    Researchers call for a major rethink of how Alzheimer's treatments are evaluated.
    Nature. 2024;627:S18-S20.
    PubMed        

  38. HANEY MS, Palovics R, Munson CN, Long C, et al
    APOE4/4 is linked to damaging lipid droplets in Alzheimer's disease microglia.
    Nature. 2024 Mar 13. doi: 10.1038/s41586-024-07185.
    PubMed         Abstract available


    Nervenarzt

  39. BELTRANI S, Funk J, Lieb J, Ehrensperger MM, et al
    [An arachnoid cyst mimicking a symptomatic Alzheimer's disease].
    Nervenarzt. 2024 Mar 14. doi: 10.1007/s00115-024-01638.
    PubMed        


    Neurobiol Aging

  40. ALMEIDA FC, Jesus T, Coelho A, Quintas-Neves M, et al
    Psychosis in Alzheimer's disease is associated with specific changes in brain MRI volume, cognition and neuropathology.
    Neurobiol Aging. 2024;138:10-18.
    PubMed         Abstract available


    Neurologia (Engl Ed)

  41. ZHANG WT, Zhang GX, Gao SS
    The potential diagnostic accuracy of circulating microRNAs for Alzheimer's disease: A meta-analysis.
    Neurologia (Engl Ed). 2024;39:147-159.
    PubMed         Abstract available


    Neurology

  42. WEINSTEIN G, Kojis DJ, Ghosh S, Beiser AS, et al
    Association of Neurotrophic Factors at Midlife With In Vivo Measures of beta-Amyloid and Tau Burden 15 Years Later in Dementia-Free Adults.
    Neurology. 2024;102:e209198.
    PubMed         Abstract available

  43. OVEISGHARAN S, Grodstein F, Evia AM Jr, James BD, et al
    Association of Age-Related Neuropathologic Findings at Autopsy With a Claims-Based Epilepsy Diagnosis in Older Adults.
    Neurology. 2024;102:e209172.
    PubMed         Abstract available

  44. LI G, Iliff J, Shofer J, Mayer CL, et al
    CSF beta-Amyloid and Tau Biomarker Changes in Veterans With Mild Traumatic Brain Injury.
    Neurology. 2024;102:e209197.
    PubMed         Abstract available

  45. ALOSCO ML, Tartaglia MC
    Repetitive Blast Injury and CSF Alzheimer Disease Biomarkers: Navigating a Complex Narrative.
    Neurology. 2024;102:e209294.
    PubMed        

  46. NGUYEN HV, Mital S, Knopman DS, Alexander GC, et al
    Cost-Effectiveness of Lecanemab for Individuals With Early-Stage Alzheimer Disease.
    Neurology. 2024;102:e209218.
    PubMed         Abstract available

  47. NADEAU SE
    Lecanemab Questions.
    Neurology. 2024;102:e209320.
    PubMed         Abstract available

  48. NELSON SE, Lopez OL
    Lecanemab for Alzheimer Disease: Is It Worth It?
    Neurology. 2024;102:e209265.
    PubMed        

  49. LU Y, Pike JR, Hoogeveen R, Walker K, et al
    Nonalcoholic Fatty Liver Disease and Longitudinal Change in Imaging and Plasma Biomarkers of Alzheimer Disease and Vascular Pathology.
    Neurology. 2024;102:e209203.
    PubMed         Abstract available

  50. ASKEN BM, Tanner JA, Vandevrede L, Apple A, et al
    Linking Type and Extent of Head Trauma to Cavum Septum Pellucidum in Older Adults With and Without Alzheimer Disease and Related Dementias.
    Neurology. 2024;102:e209183.
    PubMed         Abstract available


    PLoS One

  51. SHAHID SS, Dzemidzic M, Butch ER, Jarvis EE, et al
    Estimating the synaptic density deficit in Alzheimer's disease using multi-contrast CEST imaging.
    PLoS One. 2024;19:e0299961.
    PubMed         Abstract available


    Science

  52. PILLER C
    'Damning' FDA inspection report undermines Alzheimer's drug.
    Science. 2024;383:1165-1166.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.